Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-03 @ 9:45 AM
Study NCT ID:
NCT01306032
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2011-02-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II ABT-888 With Cyclophosphamide
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-26
First Submit QC Date:
None
Study First Post Date:
2011-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-23
Results First Submit QC Date:
None
Results First Post Date:
2016-05-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-16
Last Update Post Date:
2017-04-26
Last Update Post Date Type:
ACTUAL